
| OPPONENT | AB | R | H | 1B | 2B | 3B | HR | BB | RBI | SO | SAC | SB | AVG | SLG | OB | OPS | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mondelez | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | .000 | .000 | .333 | .333 | |
| ASCO | 3 | 1 | 2 | 0 | 1 | 0 | 1 | 0 | 2 | 0 | 0 | 0 | .667 | 2.000 | .667 | 2.667 | |
| Novartis #2 | 2 | 1 | 2 | 1 | 0 | 0 | 1 | 1 | 1 | 0 | 0 | 0 | 1.000 | 2.500 | 1.000 | 3.500 | |
| Evonik | 3 | 1 | 2 | 0 | 2 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | .667 | 1.333 | .667 | 2.000 | |
| Pinnacle | 4 | 1 | 4 | 3 | 0 | 1 | 0 | 0 | 3 | 0 | 0 | 0 | 1.000 | 1.500 | 1.000 | 2.500 | |
| Celgene #2 | 3 | 3 | 3 | 2 | 1 | 0 | 0 | 2 | 4 | 0 | 0 | 0 | 1.000 | 1.333 | 1.000 | 2.333 | |
| Novartis #1 | 4 | 1 | 3 | 3 | 0 | 0 | 0 | 0 | 2 | 0 | 0 | 0 | .750 | .750 | .750 | 1.500 | |
| TOTAL | 21 | 8 | 16 | 9 | 4 | 1 | 2 | 4 | 13 | 0 | 0 | 0 | .762 | 1.333 | .800 | 2.133 |